Neumora Therapeutics, Inc. (NMRA) — Financial Flexibility Index
Neumora Therapeutics, Inc. (NMRA) has a Financial Flexibility Index of -1.02x as of September 2025. Free cash flow of $-46.62 Million (operating CF $-46.63 Million minus capex $16.00K) represents -1% of total liabilities ($45.67 Million). Also explore Neumora Therapeutics, Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neumora Therapeutics, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Neumora Therapeutics, Inc. across 6 annual periods. Check NMRA strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Neumora Therapeutics, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for Neumora Therapeutics, Inc.. For the full company profile including market capitalisation, see market cap of Neumora Therapeutics, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.12x | $-182.94 Million | $-182.94 Million | $29.91 Million | ▼ -1.7% |
| 2023 | -6.02x | $-163.16 Million | $-163.28 Million | $27.12 Million | ▼ -4492.3% |
| 2022 | -0.13x | $-114.39 Million | $-114.90 Million | $873.08 Million | ▼ -32.5% |
| 2021 | -0.10x | $-74.60 Million | $-75.42 Million | $754.52 Million | ▼ -13.5% |
| 2020 | -0.09x | $-25.46 Million | $-26.76 Million | $292.33 Million | ▲ +100.0% |
| 2019 | -1212.38x | $-25.46 Million | $-26.76 Million | $21.00K | — |